BioMed Nexus Data Partner Program

Put Your Company in Front of
86,757 Biotech Decision-Makers

Get a featured profile in the BioMed Nexus Industry Directory, the most visited biotech company database in the industry. Reach investors, BD teams, and enterprise buyers every day.

86,757
Newsletter Subscribers
1.4M
Monthly Impressions
100,000+
Directory Page Views
56,023
Corporate Domains

Why Companies Partner With Us

Your profile lives on the most trafficked biotech directory page on the internet, distributed daily to enterprise inboxes at Pfizer, Novartis, Merck, AstraZeneca, and 56,000+ corporate domains.

๐Ÿ”

Get Found by the Right People

BD teams, investors, and procurement officers use our directory to source partners. Your profile shows up when they're actively looking.

๐Ÿ”—

Permanent SEO Backlink

A dofollow backlink from a high-authority biotech domain. Improves your search rankings and drives organic referral traffic year-round.

๐Ÿ“Š

Stand Out From 1,881+ Companies

Free listings are name-only. Your featured profile includes logo, description, pipeline data, therapeutic tags, and funding details.

๐Ÿ“ˆ

Growing Audience Daily

30,000+ weekly visitors to the site and climbing. Your profile gets more valuable every month as our directory traffic compounds.

What Your Listing Looks Like

See the difference between a free database entry and a Data Partner profile. Which one would you want representing your company?

Free Database $0/yr
Vertex Clinical Sciences Upgrade listing โ†’
That's it. Name only.
Basic Profile $3,000/yr
Featured
VCS
Vertex Clinical Sciences
Boston, MA ยท Private ยท 450+ employees

Full-service CRO specializing in oncology and rare disease clinical trials across 28 countries...

Oncology Rare Disease Phase I-III
$180M revenue View Profile โ†’
Landing Page $5,000/yr
VCS
Vertex Clinical Sciences
biomednexus.com/company/vertex-clinical
Photo
Lab
450+
Team
28
Countries
92
Trials
SR
JK
MP
DL
Leadership
SEO-indexed on biomednexus.com

Choose Your Partnership Tier

Both tiers include featured placement, priority positioning, and a permanent backlink from the BioMed Nexus domain.

Basic Profile
$3,000 / year
A featured profile card in the directory with your company's key information front and center.
Includes
  • Company logo displayed on profile card
  • Company description (up to 150 words)
  • Dofollow backlink to your website
  • "Featured" badge and priority placement
  • Therapeutic area and technology tags
  • Funding stage and pipeline data displayed
  • Visible to all directory visitors and subscribers
Get Basic Profile โ†’
Billed annually. Live within 48 hours.

Satisfaction guarantee: If your profile doesn't generate measurable referral traffic within the first 90 days, we'll extend your listing by one quarter at no cost.

Feature Comparison

FeatureFree DatabaseBasic ProfileLanding Page
Company name in directoryโœ“โœ“โœ“
Company logoโ€”โœ“โœ“
Company descriptionโ€”โœ“โœ“
Dofollow backlinkโ€”โœ“โœ“
"Featured" badgeโ€”โœ“โœ“
Therapeutic area tagsโ€”โœ“โœ“
Funding and pipeline dataโ€”โœ“โœ“
Dedicated landing page on biomednexus.comโ€”โ€”โœ“
Extended overview with imagesโ€”โ€”โœ“
Leadership team profilesโ€”โ€”โœ“
Embedded video or mediaโ€”โ€”โœ“
Permanent SEO indexingโ€”โ€”โœ“
Linked from editorial coverageโ€”โ€”โœ“

Built for Biotech Companies That Want to Be Found

Our data partners span every stage and therapeutic area.

๐Ÿงฌ

AI Drug Discovery Platforms

Generative chemistry, computational biology, target identification, and phenomics companies looking for pharma partnerships and investor visibility.

๐Ÿข

CROs and CDMOs

Contract research and manufacturing organizations that want to be found by biotech companies actively sourcing partners through our directory.

๐Ÿ”ฌ

Clinical Trial Tech

Decentralized trial platforms, eClinical tools, and patient recruitment companies selling into the enterprise biopharma buyers in our audience.

๐Ÿ’ฐ

Biotech Service Providers

Recruiting firms, IP attorneys, regulatory consultants, and biotech SaaS tools that serve the professionals reading BioMed Nexus daily.

Frequently Asked Questions

How quickly will my profile go live? +
Basic Profiles go live within 48 hours of payment. Detailed Landing Pages include a brief onboarding call to gather your content, images, and leadership information, then typically go live within 5 business days.
What kind of backlink do I get? +
You receive a permanent dofollow backlink from biomednexus.com, a high-authority domain in the biotech space with 86,757 verified subscribers. This link passes SEO value and drives referral traffic to your website year-round.
Can I update my profile after it goes live? +
Yes. You can request updates to your profile at any time, including description changes, new pipeline data, updated funding information, or refreshed images for Landing Page tier partners. Just email our partnerships team.
Who sees my profile? +
The BioMed Nexus directory reaches biotech operators, pharma BD teams, institutional investors, and academic researchers. 64.6% of our subscriber base uses corporate email domains, including representatives from Pfizer, Novartis, Merck, AstraZeneca, BMS, Amgen, Johns Hopkins, and St. Jude.
What if I want to cancel? +
Partnerships are billed annually. If your profile doesn't generate measurable referral traffic within the first 90 days, we'll extend your listing by one quarter at no cost. There are no long-term lock-ins beyond the annual term.
What's the difference between the directory and your newsletter sponsorships? +
The Data Partner program gives you a permanent presence in our directory with ongoing visibility. Newsletter sponsorships (available separately through our media kit) are time-bound placements in the daily email. Many partners use both for maximum reach.

Your Competitors Are Already Listed

1,881+ companies are listed across our directories. 8 have featured profiles. The rest are names in a database. Which do you want to be?

Join 85,000+ Biotech, MedTech, and Pharma Leaders

Your Daily Edge in Biotech, MedTech, and Pharma

Get trusted, high-signal updates every morning
Breakthroughs, trial data, deals, and the news that matters